VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
RCUS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
RCUSArcus Biosciences, Inc.
$24.44$3.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksRCUSQuarterly Financials

Arcus Biosciences, Inc. (RCUS) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Arcus Biosciences, Inc. (RCUS) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

RCUS Income Statement

Quarterly statement

RCUS Income Statement

Arcus Biosciences, Inc. (RCUS) annual income statement — 10-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue41M17M33M26M160M28M26M48M39M145M31M32M29M25M33.66M33M27M18M354.5M9.46M
Revenue Growth %-74.38%-39.29%26.92%-45.83%310.26%-80.69%-16.13%50%34.48%480%-7.89%-3.03%7.41%38.89%-90.51%248.8%185.38%90.25%3636.68%-85.34%
Cost of Goods Sold02M3M2M0000000000000000
COGS % of Revenue-11.76%9.09%7.69%----------------
Gross Profit41M15M30M24M160M28M26M48M39M145M31M32M29M25M33.66M33M27M18M354.5M9.46M
Gross Margin %100%88.24%90.91%92.31%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %-74.38%-46.43%15.38%-50%310.26%-80.69%-16.13%50%34.48%480%-7.89%-3.03%7.41%38.89%-90.51%248.8%185.38%90.25%3636.68%-85.34%
Operating Expenses137M149M144M166M168M150M129M153M145M161M122M112M112M111M108.1M103M96M85M73.23M87.6M
OpEx % of Revenue334.15%876.47%436.36%638.46%105%535.71%496.15%318.75%371.79%111.03%393.55%350%386.21%444%321.19%312.12%355.56%472.22%20.66%925.87%
Selling, General & Admin24M29M26M27M29M28M28M30M30M32M29M30M28M30M27.9M26M26M24M23.3M16.34M
SG&A % of Revenue58.54%170.59%78.79%103.85%18.13%100%107.69%62.5%76.92%22.07%93.55%93.75%96.55%120%82.89%78.79%96.3%133.33%6.57%172.74%
Research & Development113M122M121M141M139M122M101M123M115M109M93M82M84M81M80.2M77M70M61M49.94M71.25M
R&D % of Revenue275.61%717.65%366.67%542.31%86.88%435.71%388.46%256.25%294.87%75.17%300%256.25%289.66%324%238.3%233.33%259.26%338.89%14.09%753.13%
Other Operating Expenses0-1000K-1000K-1000K000001000K0000000000
Operating Income-96M-134M-114M-142M-8M-122M-103M-105M-106M-16M-91M-80M-83M-86M-74.44M-70M-69M-67M281.27M-78.14M
Operating Margin %-234.15%-788.24%-345.45%-546.15%-5%-435.71%-396.15%-218.75%-271.79%-11.03%-293.55%-250%-286.21%-344%-221.19%-212.12%-255.56%-372.22%79.34%-825.87%
Operating Income Growth %-1100%-9.84%-10.68%-35.24%92.45%-662.5%-13.19%-31.25%-27.71%81.4%-22.24%-14.29%-20.29%-28.36%-126.47%10.41%9.37%7.9%640.77%-5134.54%
EBITDA-93M-132M-111M-140M-6M-119M-100M-103M-104M-13M-88M-79M-81M-84M-72.96M-68M-67M-66M280.83M-77.17M
EBITDA Margin %-226.83%-776.47%-336.36%-538.46%-3.75%-425%-384.62%-214.58%-266.67%-8.97%-283.87%-246.88%-279.31%-336%-216.8%-206.06%-248.15%-366.67%79.22%-815.7%
EBITDA Growth %-1450%-10.92%-11%-35.92%94.23%-815.38%-13.64%-30.38%-28.4%84.52%-20.61%-16.18%-20.9%-27.27%-125.98%11.89%11.04%8.27%659.5%-3124.02%
D&A (Non-Cash Add-back)3M2M3M2M2M3M3M2M2M3M3M1M2M2M1.48M2M2M1M-441K963K
EBIT-88M-125M-84M-132M2M-111M-92M-91M-93M-3M-80M-68M-74M-77M-66.9M-65M-66M-67M281.92M-77.97M
Net Interest Income5M6M17M7M8M10M10M13M13M12M11M11M9M8M6.98M5M2M0-260K161K
Interest Income8M9M31M10M10M11M12M14M13M13M11M12M9M9M7.54M5M3M00161K
Interest Expense3M3M14M3M2M1M2M1M01M01M01M563K01M0260K0
Other Income/Expense5M6M16M7M010M9M13M13M12M11M11M9M8M6.98M5M2M0-84K161K
Pretax Income-91M-128M-98M-135M-8M-112M-94M-92M-93M-4M-80M-69M-74M-78M-67.46M-65M-67M-67M281.18M-77.97M
Pretax Margin %-221.95%-752.94%-296.97%-519.23%-5%-400%-361.54%-191.67%-238.46%-2.76%-258.06%-215.63%-255.17%-312%-200.45%-196.97%-248.15%-372.22%79.32%-824.17%
Income Tax0000001M0001M2M1M2M-4K001M1.81M0
Effective Tax Rate %0%0%0%0%0%0%-1.06%0%0%0%-1.25%-2.9%-1.35%-2.56%0.01%0%0%-1.49%0.65%0%
Net Income-91M-128M-98M-135M-8M-112M-94M-92M-93M-4M-81M-71M-75M-80M-67.46M-65M-67M-68M279.37M-77.97M
Net Margin %-221.95%-752.94%-296.97%-519.23%-5%-400%-361.54%-191.67%-238.46%-2.76%-261.29%-221.88%-258.62%-320%-200.43%-196.97%-248.15%-377.78%78.81%-824.17%
Net Income Growth %-1037.5%-14.29%-4.26%-46.74%91.4%-2700%-16.05%-29.58%-24%95%-20.08%-9.23%-11.94%-17.65%-124.15%16.64%11.81%6.33%638.77%-4379.64%
Net Income (Continuing)-91M-128M-98M-135M-8M-112M-95M-92M-93M-4M-81M-71M-75M-80M-67.46M-65M-67M-68M279.37M-77.97M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.72-1.02-0.92-1.270.04-1.14-1.03-1.01-1.02-0.05-1.08-0.95-1.02-1.10-0.92-0.84-0.90-0.963.71-1.11
EPS Growth %-1758.99%10.53%10.68%-25.74%104.25%-2356.9%4.63%-6.32%0%95.78%-17.39%-13.1%-13.33%-14.58%-124.8%24.32%17.43%11.11%552.44%-3800%
EPS (Basic)-0.72-1.02-0.92-1.270.04-1.14-1.03-1.01-1.02-0.05-1.08-0.95-1.02-1.10-0.92-0.84-0.90-0.963.97-1.11
Diluted Shares Outstanding126.1M125.4M107.4M106.5M106.5M98.4M91.7M91.4M91.1M86.2M75M74.6M73.2M73M72.6M72.24M71.81M71.19M75.36M70.11M
Basic Shares Outstanding126.1M125.4M107.4M106.5M106.1M98.4M91.7M91.4M91.1M86.2M75M74.6M73.2M73M72.6M72.2M71.8M71.19M70.4M70.11M
Dividend Payout Ratio--------------------